151 related articles for article (PubMed ID: 12565984)
1. Predictive factors for blastoid transformation in the common variant of mantle cell lymphoma.
Räty R; Franssila K; Jansson SE; Joensuu H; Wartiovaara-Kautto U; Elonen E
Eur J Cancer; 2003 Feb; 39(3):321-9. PubMed ID: 12565984
[TBL] [Abstract][Full Text] [Related]
2. Sequence analysis proves clonal identity in five patients with typical and blastoid mantle cell lymphoma.
Yin CC; Medeiros LJ; Cromwell CC; Mehta AP; Lin P; Luthra R; Abruzzo LV
Mod Pathol; 2007 Jan; 20(1):1-7. PubMed ID: 17057651
[TBL] [Abstract][Full Text] [Related]
3. Ki-67 Labeling Indices in 'Classic' versus 'Blastoid' Mantle Cell Lymphomas--Proposed Cutoff Values for Routine Diagnostic Workup.
Pervez S; Haroon S; Awan D
Asian Pac J Cancer Prev; 2015; 16(15):6591-4. PubMed ID: 26434879
[TBL] [Abstract][Full Text] [Related]
4. Blastoid and common variants of mantle cell lymphoma exhibit distinct immunophenotypic and interphase FISH features.
Parrens M; Belaud-Rotureau MA; Fitoussi O; Carerre N; Bouabdallah K; Marit G; Dubus P; de Mascarel A; Merlio JP
Histopathology; 2006 Mar; 48(4):353-62. PubMed ID: 16487357
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network.
Hoster E; Rosenwald A; Berger F; Bernd HW; Hartmann S; Loddenkemper C; Barth TF; Brousse N; Pileri S; Rymkiewicz G; Kodet R; Stilgenbauer S; Forstpointner R; Thieblemont C; Hallek M; Coiffier B; Vehling-Kaiser U; Bouabdallah R; Kanz L; Pfreundschuh M; Schmidt C; Ribrag V; Hiddemann W; Unterhalt M; Kluin-Nelemans JC; Hermine O; Dreyling MH; Klapper W
J Clin Oncol; 2016 Apr; 34(12):1386-94. PubMed ID: 26926679
[TBL] [Abstract][Full Text] [Related]
6. Ki-67 is a strong predictor of central nervous system relapse in patients with mantle cell lymphoma (MCL).
Chihara D; Asano N; Ohmachi K; Nishikori M; Okamoto M; Sawa M; Sakai R; Okoshi Y; Tsukamoto N; Yakushijin Y; Nakamura S; Kinoshita T; Ogura M; Suzuki R
Ann Oncol; 2015 May; 26(5):966-973. PubMed ID: 25712457
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of diagnosing mantle cell lymphoma and identifying its variants on fine-needle aspiration biopsy.
Foshat M; Stewart J; Khoury JD; Staerkel GA; Caraway NP
Cancer Cytopathol; 2019 Feb; 127(1):44-51. PubMed ID: 30452126
[TBL] [Abstract][Full Text] [Related]
8. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091
[TBL] [Abstract][Full Text] [Related]
9. Mantle Cell Lymphoma Involving Skin: A Clinicopathologic Study of 37 Cases.
Kim DH; Medeiros LJ; Aung PP; Young KH; Miranda RN; Ok CY
Am J Surg Pathol; 2019 Oct; 43(10):1421-1428. PubMed ID: 31219818
[TBL] [Abstract][Full Text] [Related]
10. Ki-67 expression level, histological subtype, and the International Prognostic Index as outcome predictors in mantle cell lymphoma.
Räty R; Franssila K; Joensuu H; Teerenhovi L; Elonen E
Eur J Haematol; 2002 Jul; 69(1):11-20. PubMed ID: 12270057
[TBL] [Abstract][Full Text] [Related]
11. Blastoid variant of mantle cell lymphoma: late progression from classical mantle cell lymphoma and quantitation of minimal residual disease.
Pott C; Schrader C; Brüggemann M; Ritgen M; Harder L; Raff T; Tiemann M; Dreger P; Kneba M
Eur J Haematol; 2005 Apr; 74(4):353-8. PubMed ID: 15777349
[TBL] [Abstract][Full Text] [Related]
12. p53 and mdm2 in mantle cell lymphoma in leukemic phase.
Solenthaler M; Matutes E; Brito-Babapulle V; Morilla R; Catovsky D
Haematologica; 2002 Nov; 87(11):1141-50. PubMed ID: 12414343
[TBL] [Abstract][Full Text] [Related]
13. Mantle cell lymphoma with skin invasion characterized by the common variant in the subcutis and blastoid transformation in the overlying dermis.
Ishibashi M; Yamamoto K; Kudo S; Chen KR
Am J Dermatopathol; 2010 Apr; 32(2):180-2. PubMed ID: 20010283
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic findings in blastoid mantle cell lymphoma.
Khoury JD; Sen F; Abruzzo LV; Hayes K; Glassman A; Medeiros LJ
Hum Pathol; 2003 Oct; 34(10):1022-9. PubMed ID: 14608536
[TBL] [Abstract][Full Text] [Related]
15. MYC overexpression correlates with MYC amplification or translocation, and is associated with poor prognosis in mantle cell lymphoma.
Choe JY; Yun JY; Na HY; Huh J; Shin SJ; Kim HJ; Paik JH; Kim YA; Nam SJ; Jeon YK; Park G; Kim JE
Histopathology; 2016 Feb; 68(3):442-9. PubMed ID: 26100211
[TBL] [Abstract][Full Text] [Related]
16. Palatine Tonsils Primary Presentation of Blastoid Variant of Mantle Cell Lymphoma: Case Report.
Marques JAS; Ferreira F; Melo DP; Santos M; Vaz RP
Head Neck Pathol; 2021 Jun; 15(2):588-592. PubMed ID: 33091144
[TBL] [Abstract][Full Text] [Related]
17. Blastoid variant of mantle cell lymphoma in palatine tonsil.
Valente VB; de Castro TF; Takamiya AS; Callestini R; Xavier-Junior JCC; Cortopassi GM; Neto SC; Collado FU; Biasoli ÉR; Miyahara GI; Bernabé DG
Oral Oncol; 2021 Nov; 122():105552. PubMed ID: 34610523
[TBL] [Abstract][Full Text] [Related]
18. Expression of Mcl-1 in mantle cell lymphoma is associated with high-grade morphology, a high proliferative state, and p53 overexpression.
Khoury JD; Medeiros LJ; Rassidakis GZ; McDonnell TJ; Abruzzo LV; Lai R
J Pathol; 2003 Jan; 199(1):90-7. PubMed ID: 12474231
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value and computer image analysis of p53 in mantle cell lymphoma.
Zhang YH; Gao LM; Xiang XY; Zhang WY; Liu WP
Ann Hematol; 2022 Oct; 101(10):2271-2279. PubMed ID: 35918462
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic features, management and outcomes of blastoid variant of mantle cell lymphoma: a Nebraska Lymphoma Study Group Experience.
Bhatt VR; Loberiza FR; Smith LM; Armitage JO; Greiner TC; Bast M; Lunning MA; Bierman PJ; Vose JM; Bociek RG
Leuk Lymphoma; 2016; 57(6):1327-34. PubMed ID: 26377137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]